result line compani neg pre-announc late march
unabl realiz march pe price hike though guidanc expect
headwind remain pe price seen recent support see near-term increment
ethylen margin pressur pt impli ev/ebitda
respect well dividend yield
pro forma ebitda bb bb line
updat guidanc bb provid end march lower guidanc
bb provid end januari largest hit ebitda y/i came pe margin
compress follow lower equiti earn isocyan margin compress
siloxan margin compress mm mm
lower earn partial off-set capac reserv payment meglob relat
cracker expans support meglob new facil freeport
continu target mm increment save mm cost synergi
mm strand cost remov realiz anoth increment
save expect
packag specialti plastic ebitda pro forma ebitda mm
declin lower price y/i pe ethylen lower volum
y/i hydrocarbon lower equiti earn kuwait jv lower
meg price higher turnaround cost headwind off-set sever
tailwind includ cost synergi save increas pe volum new capac lower
raw materi cost lower turnaround cost ex jv lower start-up cost equiti
earn packag specialti plastic mm mm
pe volum growth driven ad capac usgc sold larg apac
emea off-set lower hydrocarbon sale y/i volum
result increas intern use ethylen pe product lower sale ethylen
co-product due increas use ethan feedstock
perform materi coat ebitda pro forma ebitda mm
declin lower siloxan price ship restrict
perform monom deer park facil due fire itc deer park termin coat
 perform monom sale y/i lower architectur binder
function coat volum consum solut sale flat y/i volum growth
off-set lower siloxan price
industri intermedi infrastructur ebitda pro forma ebitda
mm declin lower price y/i isocyan mdi tdi
meg also impact equiti earn kuwait jv meg margin pressur
sadara isocyan margin pressur industri intermedi infrastructur equiti
earn mm mm
guidanc estim
provid revenu guidanc bb ebit driver three
segment estim impli ebitda guidanc bb guidanc
includ mm increas turnaround spend compar ebitda
project lower bb bb
pleas see page report import disclosur
capabl transform premier compani premium multipl
howev statu earn undergo cultur metamorphosi dow
new focu oper financi effici characterist old lack
pt impli ev/ebitda respect
synergi elimin
cost synergi realiz
deliv cost synergi run-rat
end
strand cost remov
realiz
pe chain margin contract new
mm share repurchas
acceler time synergi realiz
pe chain margin contract less
expect new suppli come
near-term target achiev
slower expect time synergi
pe chain margin contract
expect new suppli come
histori lead global chemic compani compris six
retain global busi unit histor combin consolid
corn ethylen copolym busi histor dupont
compani primarili serv consum care infrastructur packag market
industri lead posit number product includ silicon architectur
coat propylen oxid propylen glycol polyethylen six busi unit
spilt across three oper segment perform materi coat includ
consum solut coat perform monom industri intermedi
infrastructur industri solut polyurethan cav packag specialti
plastic hydrocarbon packag specialti plastic ebitda
packag specialti plastic account roughli half make segment
key valuat growth prospect
packag specialti plastic revenu guidanc q/q
y/i driven lower pe price lower hydrocarbon volum exclud
increas turnaround mm q/q expect core ebitda improv sequenti
support us pe contract price increas april initi increas
pe price may note pe price seen recent support us spot
ethylen track sequenti headwind given
averag spot price expect ethylen price start see rebound
addit pe capac usgc schedul start-up ramp
increas ethylen demand note increment pe suppli may pressur pe price
start ebitda project mm mm
due higher turnaround compar ethylen margin pressur mostli off-set
perform materi coat revenu guidanc q/q
y/i lower siloxan price segment face mm sequenti headwind
ship issu relat itc deep park fire mm increas turnaround
mm ebitda project mm roughli flat mm
expect cost synergi save benefit recent debottleneck add silicon
capac offset two headwind mention
industri intermedi infrastructur revenu guidanc q/q
y/i lower isocyan price equiti earn guidanc flat
segment face mm sequenti headwind increas turnaround
ebitda project mm mm improv mdi margin
season cost synergi save expect meg continu weigh result
new suppli sasol meglob ramp usgc
plan market june open program buy back share
manag guid mm share repurchas bb
cowen compani
consolid million except share salesperform materi intermedi specialti adjust ebitda perform materi intermedi specialti adjust segment adjust ebitda margin perform materi intermedi specialti adjust ebitda continu oper tax incom expens amort debt exchang gain signific adjust net net incom cowen
util blend histor rel earn ebitda multipl compar
compani analysi free cash flow yield dividend yield longer term discount cash flow
model arriv price target
risk includ stronger anticip econom recoveri stimul higher
anticip demand commod product slate raw materi price pressur
materi differ underli expect suppli chang differ
plan expect greater anticip capit intens cost cut
compani specif synergi differ materi expect
upsid risk price target includ higher anticip sale volum price
due demand improv and/or suppli constraint lower anticip
cost structur downsid risk price target includ weaker anticip sale
volum price higher anticip cost structur
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock nutrien olin corp secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc may et dissemin may et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
